>  <GSRS_JSON>
{"uuid":"c22ee4ec-df65-8964-b7d4-3c245490d9dc","created":1551107333084,"createdBy":"CALLAHANL","lastEdited":1553725130507,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"definitionType":"PRIMARY","definitionLevel":"COMPLETE","substanceClass":"structurallyDiverse","status":"approved","version":"8","approvedBy":"YOSHIYUKI.TOKIWA","approved":1553724982129,"changeReason":"Modified polysaccharide/protein ratio","names":[{"uuid":"df2aff48-739f-13cd-2a34-0e35d9991ae8","created":1551107333156,"createdBy":"CALLAHANL","lastEdited":1553725130539,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"name":"EXPEC-4V COMPONENT O6-POLYSACCHARIDE BIOCONJUGATE","type":"cn","domains":[],"languages":["en"],"nameJurisdiction":[],"nameOrgs":[],"preferred":false,"displayName":false,"references":["92c218e4-b5fd-0b94-8df3-3024a37c1f0b","5adc0b19-da60-dcff-c559-488c921a504e"],"access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/names(df2aff48-739f-13cd-2a34-0e35d9991ae8)?view=full"},{"uuid":"7e372403-233b-751e-d40f-e7dfda684824","created":1551107333153,"createdBy":"CALLAHANL","lastEdited":1553725130538,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"name":"ESCHERICHIA COLI SEROTYPE O6 O-POLYSACCHARIDE EXOTOXIN A TOXOID BIOCONJUGATE","type":"cn","domains":[],"languages":["en"],"nameJurisdiction":[],"nameOrgs":[],"preferred":false,"displayName":false,"references":["92c218e4-b5fd-0b94-8df3-3024a37c1f0b","5adc0b19-da60-dcff-c559-488c921a504e"],"access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/names(7e372403-233b-751e-d40f-e7dfda684824)?view=full"},{"uuid":"91ab0cad-d899-4794-ab45-f2ec8aff1d85","created":1551107333144,"createdBy":"CALLAHANL","lastEdited":1553725130537,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"name":"JNJ63871860 COMPONENT O6-POLYSACCHARIDE BIOCONJUGATE","type":"cd","domains":[],"languages":["en"],"nameJurisdiction":[],"nameOrgs":[],"preferred":false,"displayName":false,"references":["92c218e4-b5fd-0b94-8df3-3024a37c1f0b","5adc0b19-da60-dcff-c559-488c921a504e"],"access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/names(91ab0cad-d899-4794-ab45-f2ec8aff1d85)?view=full"},{"uuid":"5302f9de-e563-7df9-ebc2-3f21c188eae8","created":1551108781992,"createdBy":"CALLAHANL","lastEdited":1553725130536,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"name":"JNJ-63871860 COMPONENT O6-POLYSACCHARIDE BIOCONJUGATE","type":"cd","domains":[],"languages":["en"],"nameJurisdiction":[],"nameOrgs":[],"preferred":false,"displayName":true,"references":["5adc0b19-da60-dcff-c559-488c921a504e"],"access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/names(5302f9de-e563-7df9-ebc2-3f21c188eae8)?view=full"}],"codes":[{"uuid":"0bbbaf52-c83e-4897-a435-10b9c0ce930b","created":1551107333159,"createdBy":"CALLAHANL","lastEdited":1551107333159,"lastEditedBy":"CALLAHANL","deprecated":false,"codeSystem":"BDNUM","code":"0118242AB","type":"PRIMARY","references":["384a91e3-74f9-4647-a25a-e92202fd2be3"],"access":["protected"],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/codes(0bbbaf52-c83e-4897-a435-10b9c0ce930b)?view=full"}],"modifications":{"uuid":"2398a3c8-389c-db08-43cc-a43adba035ec","created":1551107333017,"createdBy":"CALLAHANL","lastEdited":1553725130498,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"agentModifications":[],"physicalModifications":[],"structuralModifications":[{"uuid":"5343feda-a30b-c7db-414f-0cc34dac0103","created":1551107333055,"createdBy":"CALLAHANL","lastEdited":1553725130488,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"structuralModificationType":"PROTEIN CONJUGATION","locationType":"RESIDUE_SPECIFIC","residueModified":"ASPARAGINE","extent":"PARTIAL","extentAmount":{"uuid":"9da93a18-3ad3-cb4a-dad5-157178c186a2","created":1551107333042,"createdBy":"CALLAHANL","lastEdited":1553725130464,"lastEditedBy":"YOSHIYUKI.TOKIWA","deprecated":false,"type":"WEIGHT PERCENT","high":38,"low":32,"units":"%","nonNumericValue":"POLYSACCHARIDE/PROTEIN","references":[],"access":[]},"molecularFragment":{"uuid":"ae9a9825-0ee1-b3d7-c673-f11cefb135b7","created":1551107333052,"createdBy":"CALLAHANL","lastEdited":1551107333052,"lastEditedBy":"CALLAHANL","deprecated":false,"refPname":"ETA E553 DELETION","refuuid":"06d07875-55ff-4ae4-983b-7b2b1de877ef","substanceClass":"reference","approvalID":"TN25NL6LXJ","linkingID":"TN25NL6LXJ","name":"ETA E553 DELETION","references":[],"access":[]},"modificationGroup":"1","sites":[],"references":[],"access":[]}],"references":[],"access":[]},"notes":[{"uuid":"d9b21fed-3f8d-4799-15c6-3ba66b81b664","created":1551107333184,"createdBy":"CALLAHANL","lastEdited":1551107333184,"lastEditedBy":"CALLAHANL","deprecated":false,"note":"[Validation]WARNING:Structurally diverse organism substance typically should not specify both a parent and taxonomic information","references":[],"access":["admin"]},{"uuid":"579fe31d-b8c1-4d4b-9645-cc67030f36a1","created":1551121424315,"createdBy":"CALLAHANL","lastEdited":1551121424315,"lastEditedBy":"CALLAHANL","deprecated":false,"note":"ExPEC-4V bioconjugate vaccine was produced in recombinant E. coli W3110 strains (ΔwaaL, ΔrfbO16::rfb of the relevant O antigen), engineered using site-directed genomic integration to express the wild-type polysaccharide biosynthesis cluster of the corresponding source serotype under control of the native promoter. EPA was expressed from a high-copy number plasmid under control of an arabinose-inducible promoter [18], [19]. The oligosaccharyl transferase PglB from Campylobacter jejuni, required for specific N-linked protein glycosylation in E. coli, was expressed from a low-copy number expression plasmid under control of an IPTG-inducible hybrid promoter","references":[],"access":[]}],"properties":[],"relationships":[{"uuid":"f78ba8d8-c583-40b9-aca4-c56e9e598c72","created":1551107756203,"createdBy":"CALLAHANL","lastEdited":1551107756203,"lastEditedBy":"CALLAHANL","deprecated":false,"relatedSubstance":{"uuid":"fc9ae74f-45ec-4e16-9e4c-c5d3e2210921","created":1551107756192,"createdBy":"CALLAHANL","lastEdited":1551107756192,"lastEditedBy":"CALLAHANL","deprecated":false,"refPname":"JNJ-63871860 COMPONENT O6-POLYSACCHARIDE BIOCONJUGATE","refuuid":"c22ee4ec-df65-8964-b7d4-3c245490d9dc","substanceClass":"reference","approvalID":"X7R0M59LQ6","linkingID":"X7R0M59LQ6","name":"JNJ-63871860 COMPONENT O6-POLYSACCHARIDE BIOCONJUGATE","references":[],"access":[]},"originatorUuid":"f78ba8d8-c583-40b9-aca4-c56e9e598c72","type":"ACTIVE MOIETY","references":["5adc0b19-da60-dcff-c559-488c921a504e","90510745-46ce-4f41-af47-6bb87bb37fe9"],"access":[]},{"uuid":"b89fc0f6-2f13-6720-0c66-ae1dbc339d73","created":1551107333198,"createdBy":"CALLAHANL","lastEdited":1551107333198,"lastEditedBy":"CALLAHANL","deprecated":false,"relatedSubstance":{"uuid":"19dcfcab-bbe7-4193-a905-fb41966b87fa","created":1551107333196,"createdBy":"CALLAHANL","lastEdited":1551107333196,"lastEditedBy":"CALLAHANL","deprecated":false,"refPname":"ESCHERICHIA COLI SEROTYPE O6","refuuid":"524a7836-d749-45cf-2e56-0ae124a10a1f","substanceClass":"reference","approvalID":"8Z8ONY8C9H","linkingID":"8Z8ONY8C9H","name":"ESCHERICHIA COLI SEROTYPE O6","references":[],"access":[]},"originatorUuid":"601b4da2-fc68-4905-afbc-73d91fd0a45c","type":"TARGET->ANTIGEN","references":["5adc0b19-da60-dcff-c559-488c921a504e"],"access":[]}],"references":[{"uuid":"384a91e3-74f9-4647-a25a-e92202fd2be3","created":1551107333308,"createdBy":"CALLAHANL","lastEdited":1551107333308,"lastEditedBy":"CALLAHANL","deprecated":false,"citation":"System Generated Code","docType":"SYSTEM","publicDomain":false,"tags":[],"access":["protected"],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/references(384a91e3-74f9-4647-a25a-e92202fd2be3)?view=full"},{"uuid":"90510745-46ce-4f41-af47-6bb87bb37fe9","created":1551107333306,"createdBy":"CALLAHANL","lastEdited":1551107333306,"lastEditedBy":"CALLAHANL","deprecated":false,"citation":"Van den Dobbelsteen, Germie PJM, et al. \"Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models.\" Vaccine 34.35 (2016): 4152-4160.","docType":"JA","publicDomain":true,"tags":["PUBLIC_DOMAIN_RELEASE"],"url":"https://www.sciencedirect.com/science/article/pii/S0264410X16305187","access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/references(90510745-46ce-4f41-af47-6bb87bb37fe9)?view=full"},{"uuid":"5adc0b19-da60-dcff-c559-488c921a504e","created":1551107333303,"createdBy":"CALLAHANL","lastEdited":1551107333303,"lastEditedBy":"CALLAHANL","deprecated":false,"citation":"Inoue, Megumi, et al. \"Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants.\" Human vaccines & immunotherapeutics 14.9 (2018): 2150-2157.","docType":"JA","documentDate":1493391240000,"publicDomain":true,"tags":["NOMEN","PUBLIC_DOMAIN_RELEASE"],"url":"https://www.tandfonline.com/doi/abs/10.1080/21645515.2018.1474316","access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/references(5adc0b19-da60-dcff-c559-488c921a504e)?view=full"},{"uuid":"92c218e4-b5fd-0b94-8df3-3024a37c1f0b","created":1551107333301,"createdBy":"CALLAHANL","lastEdited":1551107333301,"lastEditedBy":"CALLAHANL","deprecated":false,"citation":"FDA_SRS","docType":"SRS","publicDomain":true,"tags":[],"access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/references(92c218e4-b5fd-0b94-8df3-3024a37c1f0b)?view=full"}],"approvalID":"X7R0M59LQ6","tags":["WHO-DD","VANDF","VANDF"],"structurallyDiverse":{"uuid":"acabd2df-9e59-5885-6118-101c9618c198","created":1551107333074,"createdBy":"CALLAHANL","lastEdited":1551107333074,"lastEditedBy":"CALLAHANL","deprecated":false,"sourceMaterialClass":"ORGANISM","sourceMaterialType":"BACTERIUM","organismFamily":"ENTEROBACTERIACEAE","organismGenus":"ESCHERICHIA","organismSpecies":"COLI","organismAuthor":"(MIGULA, 1895) CASTELLANI AND CHALMERS, 1919","part":["CELL WALL"],"infraSpecificType":"SEROTYPE","infraSpecificName":"O6","fractionName":"O-POLYSACCHARIDE","fractionMaterialType":"POLYSACCHARIDE","parentSubstance":{"uuid":"7eeaa5c6-d232-4836-91a4-0d8fcbb053ee","created":1551107333071,"createdBy":"CALLAHANL","lastEdited":1551107333071,"lastEditedBy":"CALLAHANL","deprecated":false,"refPname":"ESCHERICHIA COLI SEROTYPE O6","refuuid":"524a7836-d749-45cf-2e56-0ae124a10a1f","substanceClass":"reference","approvalID":"8Z8ONY8C9H","linkingID":"8Z8ONY8C9H","name":"ESCHERICHIA COLI SEROTYPE O6","references":[],"access":[]},"references":["5adc0b19-da60-dcff-c559-488c921a504e"],"access":[]},"_approvalIDDisplay":"X7R0M59LQ6","_name":"JNJ-63871860 COMPONENT O6-POLYSACCHARIDE BIOCONJUGATE","access":[],"_self":"https://gsrs.fda.gov/ginas/app/api/v1/substances(c22ee4ec-df65-8964-b7d4-3c245490d9dc)?view=full"}


>  <UNII>
X7R0M59LQ6


$$$$